Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2021
Mar. 21, 2022
Jun. 30, 2021
Document Information Line Items      
Entity Registrant Name Relmada Therapeutics, Inc.    
Trading Symbol RLMD    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   29,369,490  
Entity Public Float     $ 547,451,729
Amendment Flag false    
Entity Central Index Key 0001553643    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 000-55347    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 45-5401931    
Entity Address, Address Line One 2222 Ponce de Leon Blvd    
Entity Address, Address Line Two Floor 3    
Entity Address, City or Town Coral Gables    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33134    
City Area Code (786)    
Local Phone Number 629 1376    
Title of 12(b) Security Common Stock ($.001 par value)    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Firm ID 688    
Auditor Name Marcum llp    
Auditor Location Houston, Texas